BP (LSE: BP) is one of the UK market's most trusted dividend stocks and so is its blue-chip peer GlaxoSmithKline (LSE: GSK). Together these two FTSE 100 dividend champions are are responsible for a huge chunk of the total value of dividends paid out to ...
On a forward earnings multiple, again there is nothing between GSK and AZ (15 times 2017 EPS vs 15.6). Shire, however, comes in significantly cheaper at just 13 times - with that comes underlying earnings growth of 11% this year.
Shares in FTSE 100 pharmaceutical giant GlaxoSmithKline (LSE: GSK) were in the red this afternoon. That was despite the company reporting a 21% rise in sales (in sterling terms) over the fourth quarter and “continued momentum” in 2016 as a whole.
The study, carried out by GSK's majority owned ViiV Healthcare business, showed the two drug treatment for HIV-1 was just as effective as the three or four drug regimens in virologically suppressed patients.